Literature DB >> 19629420

Novel insights into the role of the tumor suppressor von Hippel Lindau in cellular differentiation, ciliary biology, and cyst repression.

Michael S Wiesener1, Patrick H Maxwell, Kai-Uwe Eckardt.   

Abstract

The growth and differentiation of renal tubular epithelial cells is normally tightly controlled. Disturbances can lead to the development of renal cysts or renal cell carcinomas, clinically relevant disease entities, which have so far been considered as being caused by entirely distinct mechanisms. Clear cell renal carcinoma, the most frequent type of renal cancer is associated with inactivation of the von Hippel Lindau (VHL) protein. Genetic defects leading to cystic kidney disease usually affect proteins that play a role in structure or function of primary cilia of renal epithelial cells. Accumulating evidence suggests that the VHL protein also controls cilia function and that its inactivation may result in both malignant or nonmalignant growth of epithelial cells and that this effect is in part mediated through the accumulation of hypoxia-inducible factors. Unraveling the complex role of VHL in renal epithelial cells is likely to shed further insight into mechanism of epithelial growth control, epithelial-mesenchymal transformation, and tumor development.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19629420     DOI: 10.1007/s00109-009-0504-x

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  58 in total

1.  Lysyl oxidase is essential for hypoxia-induced metastasis.

Authors:  Janine T Erler; Kevin L Bennewith; Monica Nicolau; Nadja Dornhöfer; Christina Kong; Quynh-Thu Le; Jen-Tsan Ashley Chi; Stefanie S Jeffrey; Amato J Giaccia
Journal:  Nature       Date:  2006-04-27       Impact factor: 49.962

2.  Formation of primary cilia in the renal epithelium is regulated by the von Hippel-Lindau tumor suppressor protein.

Authors:  Miguel A Esteban; Sarah K Harten; Maxine G Tran; Patrick H Maxwell
Journal:  J Am Soc Nephrol       Date:  2006-06-14       Impact factor: 10.121

3.  The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.

Authors:  P H Maxwell; M S Wiesener; G W Chang; S C Clifford; E C Vaux; M E Cockman; C C Wykoff; C W Pugh; E R Maher; P J Ratcliffe
Journal:  Nature       Date:  1999-05-20       Impact factor: 49.962

Review 4.  Renal cystic diseases: diverse phenotypes converge on the cilium/centrosome complex.

Authors:  Lisa M Guay-Woodford
Journal:  Pediatr Nephrol       Date:  2006-07-06       Impact factor: 3.714

5.  Regulation of E-cadherin expression by VHL and hypoxia-inducible factor.

Authors:  Miguel A Esteban; Maxine G B Tran; Sarah K Harten; Peter Hill; Maria C Castellanos; Ashish Chandra; Raju Raval; Tim S O'brien; Patrick H Maxwell
Journal:  Cancer Res       Date:  2006-04-01       Impact factor: 12.701

6.  Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition.

Authors:  Debra F Higgins; Kuniko Kimura; Wanja M Bernhardt; Nikita Shrimanker; Yasuhiro Akai; Bernd Hohenstein; Yoshihiko Saito; Randall S Johnson; Matthias Kretzler; Clemens D Cohen; Kai-Uwe Eckardt; Masayuki Iwano; Volker H Haase
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

7.  A critical developmental switch defines the kinetics of kidney cyst formation after loss of Pkd1.

Authors:  Klaus Piontek; Luis F Menezes; Miguel A Garcia-Gonzalez; David L Huso; Gregory G Germino
Journal:  Nat Med       Date:  2007-10-28       Impact factor: 53.440

8.  Inversin, a novel gene in the vertebrate left-right axis pathway, is partially deleted in the inv mouse.

Authors:  D Morgan; L Turnpenny; J Goodship; W Dai; K Majumder; L Matthews; A Gardner; G Schuster; L Vien; W Harrison; F F Elder; M Penman-Splitt; P Overbeek; T Strachan
Journal:  Nat Genet       Date:  1998-10       Impact factor: 38.330

9.  Inhibition of hypoxia-inducible factor is sufficient for growth suppression of VHL-/- tumors.

Authors:  Michael Zimmer; Darrell Doucette; Naila Siddiqui; Othon Iliopoulos
Journal:  Mol Cancer Res       Date:  2004-02       Impact factor: 5.852

10.  Chlamydomonas IFT88 and its mouse homologue, polycystic kidney disease gene tg737, are required for assembly of cilia and flagella.

Authors:  G J Pazour; B L Dickert; Y Vucica; E S Seeley; J L Rosenbaum; G B Witman; D G Cole
Journal:  J Cell Biol       Date:  2000-10-30       Impact factor: 10.539

View more
  5 in total

1.  Frontiers in the pathogenesis of kidney disease.

Authors:  Kai-Uwe Eckardt
Journal:  J Mol Med (Berl)       Date:  2009-07-31       Impact factor: 4.599

Review 2.  State of the science: an update on renal cell carcinoma.

Authors:  Eric Jonasch; P Andrew Futreal; Ian J Davis; Sean T Bailey; William Y Kim; James Brugarolas; Amato J Giaccia; Ghada Kurban; Armin Pause; Judith Frydman; Amado J Zurita; Brian I Rini; Pam Sharma; Michael B Atkins; Cheryl L Walker; W Kimryn Rathmell
Journal:  Mol Cancer Res       Date:  2012-05-25       Impact factor: 5.852

3.  Longitudinal analysis of retinal hemangioblastomatosis and visual function in ocular von Hippel-Lindau disease.

Authors:  Brian C Toy; Elvira Agrón; Divya Nigam; Emily Y Chew; Wai T Wong
Journal:  Ophthalmology       Date:  2012-08-17       Impact factor: 12.079

4.  Renal tubular HIF-2α expression requires VHL inactivation and causes fibrosis and cysts.

Authors:  Ruth E Schietke; Thomas Hackenbeck; Maxine Tran; Regina Günther; Bernd Klanke; Christina L Warnecke; Karl X Knaup; Deepa Shukla; Christian Rosenberger; Robert Koesters; Sebastian Bachmann; Peter Betz; Gunnar Schley; Johannes Schödel; Carsten Willam; Thomas Winkler; Kerstin Amann; Kai-Uwe Eckardt; Patrick Maxwell; Michael S Wiesener
Journal:  PLoS One       Date:  2012-01-27       Impact factor: 3.240

5.  Chondroitin sulfate proteoglycan CSPG4 as a novel hypoxia-sensitive marker in pancreatic tumors.

Authors:  Shereen Keleg; Alexandr Titov; Anette Heller; Thomas Giese; Christine Tjaden; Sufian S Ahmad; Matthias M Gaida; Andrea S Bauer; Jens Werner; Nathalia A Giese
Journal:  PLoS One       Date:  2014-06-16       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.